On average, most individuals starting semaglutide GLP-1 treatment experience weight loss at a rate of 1-2 pounds per week
Because of PCOS, which has a common symptom of sudden weight fluctuations, Ewen went from 150 pounds to 220 pounds in eight months
Tirzepatide, the active ingredient in Zepbound and Mounjaro, is part of new class of medications used to treat obesity and diabetes that have skyrocketed in popularity, driving shortages and leading some people to use versions made by compounding pharmacies
Debe evitar la semaglutida si tiene antecedentes de pancreatitis, problemas de vescula biliar, enfermedad renal, tumores tiroideos (o antecedentes familiares de ellos), retinopata diabtica o ciertos trastornos digestivos
Adjust your timing so that each vial arrives with maximum remaining shelf life and you can use it completely within the BUD window
Patient self-monitoring plays an important role in successful therapy